BIODELIVERY SCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioDelivery Sciences International, Inc. - BDSI
BIODELIVERY SCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioDelivery Sciences International, Inc.
Feb 17, 2022 by PR Newswire
Key Facts
- and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of BioDelivery Sciences International, Inc. (NasdaqGS: BDSI) to Collegium Pharmaceutical, Inc. (NasdaqGS: COLL).
- KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
- If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-bdsi/ to learn more.
- To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.
PERSON
GEOGRAPHY
MONEY
ORGANIZATION
INFRASTRUCTURE
MISCELLANEOUS
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?